Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 8

Zeitschriftenartikel

Wollenberg, Andreas ORCID logoORCID: https://orcid.org/0000-0003-0177-8722; Thyssen, Jacob P. ORCID logoORCID: https://orcid.org/0000-0003-3770-1743; Bieber, Thomas; Chan, Gary und Kerkmann, Urs (2023): A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis. In: Journal of the European Academy of Dermatology and Venereology, Bd. 37, Nr. 10: S. 2041-2046 [PDF, 175kB]

Wollenberg, Andreas; Weidinger, Stephan; Worm, Margitta und Bieber, Thomas (2021): Tralokinumab in atopic dermatitis. In: Journal der Deutschen Dermatologischen Gesellschaft, Bd. 19, Nr. 10: S. 1435-1442

Simpson, Eric L.; Sinclair, Rodney; Forman, Seth; Wollenberg, Andreas; Aschoff, Roland; Cork, Michael; Bieber, Thomas; Thyssen, Jacob P.; Yosipovitch, Gil; Flohr, Carsten; Magnolo, Nina; Maari, Catherine; Feeney, Claire; Biswas, Pinaki; Tatulych, Svitlana; Valdez, Hernan und Rojo, Ricardo (2020): Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. In: Lancet, Bd. 396, Nr. 10246: S. 255-266

Staender, Sonja; Yosipovitch, Gil; Legat, Franz J.; Lacour, Jean-Philippe; Paul, Carle; Narbutt, Joanna; Bieber, Thomas; Misery, Laurent; Wollenberg, Andreas; Reich, Adam; Ahmad, Faiz und Piketty, Christophe (2020): Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis. In: New England Journal of Medicine, Bd. 382, Nr. 8: S. 706-716

Eyerich, Kilian; Brown, Sara J.; White, Bethany E. Perez; Tanaka, Reiko J.; Bissonette, Robert; Dhar, Sandipan; Bieber, Thomas; Hijnen, Dirk J.; Guttman-Yassky, Emma; Irvine, Alan; Thyssen, Jacob P.; Vestergaard, Christian; Werfel, Thomas; Wollenberg, Andreas; Paller, Amy S. und Reynolds, Nick J. (2019): Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council. In: Journal of Allergy and Clinical Immunology, Bd. 143, Nr. 1: S. 36-45

Simpson, Eric L.; Bruin-Weller, Marjolein; Flohr, Carsten; Ardern-Jones, Michael R.; Barbarot, Sebastien; Deleuran, Mette; Bieber, Thomas; Vestergaard, Christian; Brown, Sara J.; Cork, Michael J.; Drucker, Aaron M.; Eichenfield, Lawrence F.; Fölster-Holst, Regina; Guttman-Yassky, Emma; Nosbaum, Audrey; Reynolds, Nick J.; Silverberg, Jonathan I.; Schmitt, Jochen; Seyger, Marieke M. B.; Spuls, Phyllis I.; Stalder, Jean-Francois; Su, John C.; Takaoka, Roberto; Traidl-Hoffmann, Claudia; Thyssen, Jacob P.; Schaft, Jorien van der; Wollenberg, Andreas; Irvine, Alan D. und Paller, Amy S. (2017): When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. In: Journal of the American Academy of Dermatology, Bd. 77, Nr. 4: S. 623-633

Werfel, Thomas; Allam, Jean-Pierre; Biedermann, Tilo; Eyerich, Kilian; Gilles, Stefanie; Guttman-Yassky, Emma; Hoetzenecker, Wolfram; Knol, Edward; Simon, Hans-Uwe; Wollenberg, Andreas; Bieber, Thomas; Lauener, Roger; Schmid-Grendelmeier, Peter; Traidl-Hoffmann, Claudia und Akdis, Cezmi A. (2016): Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. In: Journal of Allergy and Clinical Immunology, Bd. 138, Nr. 2: S. 336-349

Weidinger, Stephan; Gieger, Christian; Rodriguez, Elke; Baurecht, Hansjoerg; Mempel, Martin; Klopp, Norman; Gohlke, Henning; Wagenpfeil, Stefan; Ollert, Markus; Ring, Johannes; Behrendt, Heidrun; Heinrich, Joachim; Novak, Natalija; Bieber, Thomas; Kraemer, Ursula; Berdel, Dietrich; Berg, Andrea von; Bauer, Carl Peter; Herbarth, Olf; Koletzko, Sibylle; Prokisch, Holger; Mehta, Divya; Meitinger, Thomas; Depner, Martin; Mutius, Erika von; Liang, Liming; Moffatt, Miriam; Cookson, William; Kabesch, Michael; Wichmann, Heinz-Erich und Illig, Thomas (August 2008): Genome-Wide Scan on Total Serum IgE Levels Identifies FCER1A as Novel Susceptibility Locus.
In: PLOS Genetics 4(8), e1000166 [PDF, 256kB]

Diese Liste wurde am Sat Apr 20 18:59:51 2024 CEST erstellt.